Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research.
about
Design of naltrexone-loaded hydrolyzable crosslinked nanoparticles.Randomized controlled trial of a mobile phone intervention for improving adherence to naltrexone for alcohol use disordersFacilitating factors and barriers to the use of medications in publicly funded addiction treatment organizationsDesign, synthesis, and subtype selectivity of 3,6-disubstituted β-carbolines at Bz/GABA(A)ergic receptors. SAR and studies directed toward agents for treatment of alcohol abuse.The pharmacotherapy of alcohol dependence: a state of the art review.Effects of naltrexone on neural and subjective response to alcohol in treatment-seeking alcohol-dependent patients.Clinical aspects of substance abuse in persons with schizophrenia.A double-blind, randomized trial of sertraline for alcohol dependence: moderation by age of onset [corrected] and 5-hydroxytryptamine transporter-linked promoter region genotype.Neurodevelopmental liabilities in alcohol dependence: central serotonin and dopamine dysfunction.A literature review of cost-benefit analyses for the treatment of alcohol dependence.The adoption of medications in substance abuse treatment: associations with organizational characteristics and technology clustersA single dose of kudzu extract reduces alcohol consumption in a binge drinking paradigm.Development of medications for alcohol use disorders: recent advances and ongoing challenges.Baclofen: a new drug for the treatment of alcohol dependence.Relationship between medication adherence and treatment outcomes: the COMBINE study.Acute interaction of baclofen in combination with alcohol in heavy social drinkersEffect of naltrexone during extinction of alcohol-reinforced responding and during repeated cue-conditioned reinstatement sessions in a cue exposure style treatment.Persistence with oral naltrexone for alcohol treatment: implications for health-care utilization.Use of novel technology-based techniques to improve alcohol-related outcomes in clinical trials.The BRENDA model: integrating psychosocial treatment and pharmacotherapy for the treatment of alcohol use disorders.The reinforcing properties of alcohol are mediated by GABA(A1) receptors in the ventral pallidum.Development of a two-step route to 3-PBC and βCCt, two agents active against alcohol self-administration in rodent and primate models.Synthesis of aza and carbocyclic β-carbolines for the treatment of alcohol abuse. Regiospecific solution to the problem of 3,6-disubstituted β- and aza-β-carboline specificity.Pharmacological approaches to the treatment of excessive drinking and alcohol dependence.Amisulpride does not prevent relapse in primary alcohol dependence: results of a pilot randomized, placebo-controlled trial.Central opioid receptors differentially regulate the nalmefene-induced suppression of ethanol- and saccharin-reinforced behaviors in alcohol-preferring (P) rats.Effects of naltrexone alone and in combination with acamprosate on the alcohol deprivation effect in rats.Understanding and treating alcohol dependence.Mining the nucleus accumbens proteome for novel targets of alcohol self-administration in male C57BL/6J mice.Long-term effects of pharmacotherapy on relapse prevention in alcohol dependence.Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from the British Association for Psychopharmacology.Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-AnalysisDoes glucagon-like peptide-1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence: study protocol of a randomised, double-blinded, placebo-controlled clinical trial
P2860
Q31106478-0D3BA091-6C09-4ABB-93CF-1B33D3BD6586Q33443427-B27B376A-69CB-49FB-9F87-23CB96AFC6E1Q34111054-E78486E0-004B-4E11-8652-B27A85EEACA7Q34275459-97603327-0518-4B33-A6D7-7D5BEECF910EQ34543952-F4C59558-E579-4B94-AD5D-5840BB3A1BDEQ34941455-7BB6B3A9-6548-4690-BD9F-BB1404995882Q35084956-B66A0791-6DC9-4566-82EF-FFD050217C23Q35088135-2AE50DD7-8DA9-4FC0-BE44-F05E6F607E6BQ35164057-017BD86D-0FA7-4921-935F-FF20893CCBE7Q35195707-13F7FAE0-89B0-43A7-B307-04001D7CEA7AQ35792939-D6D31545-2368-4C80-8C8E-E76465DB1199Q35876092-FB01827D-E844-4CB0-AAA3-B1DC37E66ED7Q36150622-35B7F47E-9935-40DF-80F4-9C94D6FD3230Q36558764-4339DCDA-CACE-40D2-856D-3B16AB3BA471Q36952204-AAB8D830-1B8B-4437-B59F-D40DF783E0C7Q37060525-6DC14179-BACF-44F0-9047-44A110F508DDQ37066471-A82B1FD0-BFC2-4DB3-9EB3-122114A3063FQ37120185-9C1DA5CA-7DB9-4DE9-B571-009309031A7EQ37276159-7290668A-A61C-4EB3-B48D-3AD7D9B42ACCQ37392393-2639BED2-41FB-4A1F-B94E-91F4C7D853F9Q38350547-08E1375A-DCB2-40E5-81DD-FAAA3BAFF55BQ42242863-7940F79F-DADF-4C80-A4CC-6D88B51391E9Q42675185-D614CB1A-010B-4A95-932C-B14D26310593Q43265597-9FE7C287-B2C1-4A63-B20B-6C75D2C9F250Q44190214-F04917B2-9ADF-49C2-ABB4-D673C5E0F25BQ44343370-E8042CA9-CB1A-417C-9073-A6FD388C95E9Q44407113-4F056215-A061-451D-8C06-612778804944Q44917574-2EDB0D03-0CAD-4163-93CC-D3196AA30C4BQ51765947-9647D875-EEB5-4313-9E9D-AA96F6BCCED2Q51936971-D624A532-593E-44DD-8209-6CF952BAA077Q51937580-24301EEA-D91B-48B5-A8F5-F0EB7AA12734Q56481671-D3D9A209-AF29-4A40-8DD0-1A43E80374C0Q56517489-24D27B0D-1EC1-4FC6-9FB6-02DD5B05BE0F
P2860
Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research.
@ast
Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research.
@en
Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research.
@nl
type
label
Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research.
@ast
Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research.
@en
Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research.
@nl
prefLabel
Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research.
@ast
Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research.
@en
Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research.
@nl
P356
P1476
Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research.
@en
P2093
Kranzler HR
P304
P356
10.1093/ALCALC/35.6.537
P577
2000-11-01T00:00:00Z